Persones / Equip Humà

Jordi Antón López

Buscador de publicacions

Publicacions

  • Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Raad JJ, Jarosova K, Anton-Lopez J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO).

    Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

    JOURNAL OF RHEUMATOLOGY . 43(4): 816-824. Nº de cites: 39

    [doi:10.3899/jrheum.150430]

  • Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ, Anton-Lopez J, Paediatric Rheumatology International Trials Organisation, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group and Histiocyte Society.

    2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

    ARTHRITIS & RHEUMATOLOGY . 68(3): 566-576. Nº de cites: 219

    [doi:10.1002/art.39332]

  • Grom AA, Ilowite NT, Pascual V, Brunner HI, Martini A, Lovell D, Ruperto N, Paediatric Rheumatology International Trials Organisation and the Pediatric Rheu, Leon K, Lheritier K and Abrams K.

    Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

    ARTHRITIS & RHEUMATOLOGY . 68(1): 218-228. Nº de cites: 96

    [doi:10.1002/art.39407]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E and Calzada-Hernández J.

    Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 34(3): 139-144. Nº de cites: 15

  • Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Mellins ED, Ilowite NT, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg A, Wedderburn LR, Anton-Lopez J, Schwarz T, Hinks A, Bilginer Y, Park J, Cobb J, Satorius CL, Han B, Baskin E, Signa S, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, de Bakker PI, Raychaudhuri S, Langefeld CD, Thompson S, Zeggini E, Thomson W, Kastner DL, Woo P, International Childhood Arthritis Genetics (INCHARGE) Consortium and British Society of Pediatric and Adolescent Rheumatology BSPAR Study Group.

    HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 112(52): 15970-15975. Nº de cites: 120

    [doi:10.1073/pnas.1520779112]

  • Boom V, Anton-Lopez J, Lahdenne P, Quartier P, Ravelli A, Wulffraat NM and Vastert SJ.

    Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis

    PEDIATRIC RHEUMATOLOGY . 13: 55-55. Nº de cites: 74

    [doi:10.1186/s12969-015-0055-3]

  • Calzada-Hernández J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Ricart S, Martín-de-Carpi J, García de Vicuña-Muñoz C, Torrente V, Sánchez-Manubens J, Giménez-Roca CI, Rozas L, Juncosa-Morros T, Fortuny-Guasch C and Noguera-Julián A.

    Tuberculosis in pediatric patients treated with anti-TNFa drugs: a cohort study

    PEDIATRIC RHEUMATOLOGY . 13: 54-54. Nº de cites: 33

    [doi:10.1186/s12969-015-0054-4]

  • Anton-Lopez J, Calvo I, Fernández-Martin J, Gamir ML, Merino R, Jimenez-Treviño S, Sevilla B, Cabades F, Bou-Torrent R and Arostegui JI.

    Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 33(6): 67-71. Nº de cites: 19

  • Calvo I, Anton-Lopez J, Bustabad S, Camacho M, de Inocencio J, Gamir ML, Graña J, La Cruz L, Robledillo JC, Medrano M, Merino R, Modesto C, Nuñez E, Rua MJ, Torrente-Segarra V, Vargas C, Carmona L and Loza E.

    Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset

    RHEUMATOLOGY INTERNATIONAL . 35(10): 1615-1624. Nº de cites: 23

    [doi:10.1007/s00296-015-3273-6]

  • Ter Haar NM, Oswald M, Jeyaratnam J, Anton-Lopez J, Barron KS, Brogan PA, Cantarini L, Galeotti C, Grateau G, Hentgen V, Hofer M, Kallinich T, Kone-Paut I, Lachmann HJ, Ozdogan H, Ozen S, Russo R, Simon A, Uziel Y, Wouters C, Feldman BM, Vastert SJ, Wulffraat NM, Benseler SM, Frenkel J, Gattorno M and Kuemmerle-Deschner JB.

    Recommendations for the management of autoinflammatory diseases

    ANNALS OF THE RHEUMATIC DISEASES . 74(9): 1636-1644. Nº de cites: 170

    [doi:10.1136/annrheumdis-2015-207546]